Soo Park, MD, on How Immune Checkpoint Inhibitors Are Changing the Treatment Landscape in Cutaneous Squamous Cell Carcinoma

Posted: Thursday, March 14, 2024

Soo Park, MD, of the University of California, San Diego, discusses the state of treatment for advanced head and neck cutaneous squamous cell carcinoma, which is associated with poor outcomes. Although surgery remains the standard of care, immune checkpoint inhibitors are changing how we approach this disease, Dr. Park notes.

---